Xiao‐Feng Le
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Cancer-related Molecular Pathways
Papers in
- Oncology 11
- HER2/EGFR in Cancer Research 7
- Cancer-related Molecular Pathways 2
-
- MicroRNA in disease regulation 4
- Co-authors
- Robert C. Bast (24 shared papers)Kun-Sang Chang (5 shared papers)Weiqun Mao (11 shared papers)George A. Călin (4 shared papers)Zhen Lü (6 shared papers)Peirong Yang (1 shared paper)Gordon Brent Mills (4 shared papers)Any Cheung (4 shared papers)
- Journals
- Journal of Biological Chemistry (4 papers)Clinical Cancer Research (3 papers)PLoS ONE (3 papers)Cancer (3 papers)Oncogene (3 papers)
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Xiao‐Feng Le
51 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 67
- Cancer Research 411
- Oncology 349
- Reproductive Medicine 129
- Molecular Biology 409
- Cell Biology 56
Countries citing papers authored by Xiao‐Feng Le
This map shows the geographic impact of Xiao‐Feng Le's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao‐Feng Le with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao‐Feng Le more than expected).
Fields of papers citing papers by Xiao‐Feng Le
This network shows the impact of papers produced by Xiao‐Feng Le. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao‐Feng Le. The network helps show where Xiao‐Feng Le may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiao‐Feng Le, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 244 | |
| 2 | 2003 | 126 | |
| 3 | 2004 | 122 | |
| 4 | 2010 | 121 | |
| 5 | 1996 | 116 | |
| 6 | 2018 | 105 | |
| 7 | 2012 | 91 | |
| 8 | 1998 | 89 | |
| 9 | 2014 | 80 | |
| 10 | 2010 | 79 | |
| 11 | 2010 | 79 | |
| 12 | 2011 | 70 | |
| 13 | 2011 | 64 | |
| 14 | Reexpression of the tumor suppressor gene ARHI induces apoptosis in ovarian and breast cancer cells through a caspase-independent calpain-dependent pathway. | 2002 | 63 |
| 15 | 2012 | 61 | |
| 16 | 2019 | 61 | |
| 17 | 2004 | 58 | |
| 18 | The outcome of heregulin-induced activation of ovarian cancer cells depends on the relative levels of HER-2 and HER-3 expression. | 1999 | 57 |
| 19 | 2012 | 57 | |
| 20 | 2003 | 55 |
About Xiao‐Feng Le
Xiao‐Feng Le is a scholar working on Oncology, Cancer Research, Reproductive Medicine, Cell Biology and Surgery, having authored 51 papers that have together received 2.7k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (7 papers), Spinal Fractures and Fixation Techniques (7 papers), Ovarian cancer diagnosis and treatment (5 papers), MicroRNA in disease regulation (4 papers), Microtubule and mitosis dynamics (3 papers), Retinoids in leukemia and cellular processes (3 papers), Cancer-related Molecular Pathways (2 papers) and Autophagy in Disease and Therapy (2 papers). The work is most often cited by research in Cancer Research (411 citations), Oncology (349 citations), Reproductive Medicine (129 citations), Molecular Biology (409 citations) and Cell Biology (56 citations). Xiao‐Feng Le has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Robert C. Bast, Kun-Sang Chang, Weiqun Mao, George A. Călin, Zhen Lü, Peirong Yang, Gordon Brent Mills, Any Cheung, Ruth LaPushin and Wei Tian. Their work appears in journals such as Journal of Biological Chemistry, Clinical Cancer Research, PLoS ONE, Cancer and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.